Clinical trial
Efficacy Study of LY2422347 to Treat Insomnia
NCT00259311 · Eli Lilly and Company, Industry · Completed
Key facts
| NCT number | NCT00259311 |
|---|---|
| Title | Efficacy Study of LY2422347 to Treat Insomnia |
| Official title | A Randomized, Double-Blind Comparison of 5 mg of LY2422347, 15 mg of LY2422347, and Placebo in the Treatment of Patients With Primary Insomnia |
| Lead sponsor | Eli Lilly and Company, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Sleep Initiation and Maintenance Disorders |
| Intervention type | Drug |
| Interventions | LY2422347, placebo |
| Enrollment | 400 |
| Start date | Nov 1, 2005 |
| Completion | Nov 1, 2006 |
| First posted | Nov 29, 2005 |
| Last update posted | Jan 26, 2007 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: